Condensed Statements of Shareholders' Deficiency - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			1,233,853
Beginning balance	$ (1,058,679)	$ (953,397)	$ (1,034,012)	$ (930,624)
Net loss	$ (31,925)	(25,750)	$ (56,592)	(48,523)
Ending balance (in shares)	1,233,853		1,233,853
Ending balance	$ (1,090,604)	$ (979,147)	$ (1,090,604)	$ (979,147)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Beginning balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Ending balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Ending balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	81,323	81,323	81,323	81,323
Ending balance	81,323	81,323	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(1,141,235)	(1,035,953)	(1,116,568)	(1,013,180)
Net loss	(31,925)	(25,750)	(56,592)	(48,523)
Ending balance	$ (1,173,160)	$ (1,061,703)	$ (1,173,160)	$ (1,061,703)